3.53
Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten
What drives Cumberland Pharmaceuticals Inc. stock priceUnmatched market performance - jammulinksnews.com
Cumberland Pharmaceuticals Inc. Stock Analysis and ForecastTremendous portfolio expansion - jammulinksnews.com
What analysts say about Cumberland Pharmaceuticals Inc. stockBreakthrough investment results - Autocar Professional
Is Cumberland Pharmaceuticals Inc. a good long term investmentExceptional gains - jammulinksnews.com
how cumberland pharmaceuticals inc. stock performs during market volatilityFree Elite Traders Group - Newser
Is Cumberland Pharmaceuticals Inc. stock a growth or value playSmart Money Trade Setups - Newser
Why Cumberland Pharmaceuticals Inc. stock attracts strong analyst attentionROI Driven Alerts - Newser
How Cumberland Pharmaceuticals Inc. stock performs during market volatilityBest Stocks for Capital Safety - Newser
What makes Cumberland Pharmaceuticals Inc. stock price move sharplyChart Breakout Alert - Newser
Caroline Young of Cumberland Pharmaceuticals buys CPIX shares By Investing.com - Investing.com Nigeria
Caroline Young of Cumberland Pharmaceuticals buys CPIX shares - Investing.com Australia
Cumberland Pharma CEO A J Kazimi buys shares worth $807 - Investing.com Australia
Cumberland Pharma CEO A J Kazimi buys shares worth $807 By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals Advances Ifetroban Study for SSc and SSc-PAH - The Globe and Mail
Cumberland Pharmaceuticals Inc.(NasdaqGS:CPIX) added to Russell Microcap Growth Index - MarketScreener
Cumberland reports positive DMD heart drug trial results - Investing.com
Asthma Market to Expand Significantly by 2034, States - openPR.com
Asthma Market to Expand Significantly by 2034, States DelveInsight Report | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentech - Barchart.com
Two Sigma Investments LP Has $89,000 Stake in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above Two Hundred Day Moving Average – Here’s Why - Defense World
Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock By Investing.com - Investing.com South Africa
Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):